Please use this identifier to cite or link to this item:
http://hdl.handle.net/11055/1080| Title: | A Retrospective Study of Topical Lidocaine 5% Plasters in Chronic Off-Label Pain Conditions |
| Authors: | Menz, B Wahba, M Slattery, P Thiruvenkatarajan, V Johnson, J |
| ANZCA/FPM Author: | Slattery, P Thiruvenkatarajan V Wahba, M |
| Keywords: | Chronic Pain Lidocaine Herpes Zoster Retrospective Studies |
| Abstract: | Dear Editor, Among many formulations, lidocaine (lignocaine) is available in a transdermal plaster (patch) containing 5% w/w lidocaine (Versatis®, trademark of Grünenthal GmbH used by Seqirus as an authorized user). This formulation is approved for symptomatic treatment of neuropathic pain associated with herpes zoster infection (post-herpetic neuralgia); thus, use of these plasters for other pain conditions is considered off-label. The use of lidocaine 5% plasters (L5%P) in off-label indications has been explored in a limited number of small studies. Currently, L5%P are recommended as a second-line treatment for neuropathic pain in a systematic review by Finnerup et al., limited by weak... |
| Description: | Ethics and governance: This project was approved by the Southern Adelaide Local Health Network Human Research Ethics Committee under reference AUD/19/SAC/76 and site-specific assessment reference AR/19/SAC/76 |
| URI: | http://hdl.handle.net/11055/1080 |
| DOI: | 10.1093/pm/pnaa408 |
| ORCID: | 0000-0002-0855-5081 |
| ISSN: | 1526-2375 |
| Journal Title: | Pain Medicine |
| Type: | Journal Article |
| Study/Trial: | Study |
| Appears in Collections: | Scholarly and Clinical |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.